| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/29/2004 | WO2004005470A3 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 04/29/2004 | WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders |
| 04/29/2004 | WO2003090529A3 Methods for identifying and using insecticides |
| 04/29/2004 | WO2003075840A3 Human antibodies specific to kdr and uses thereof |
| 04/29/2004 | WO2003065973A3 Multivalent streptococcal vaccine compositions and methods for use |
| 04/29/2004 | WO2003063575A8 Endothelialization of vascular surfaces |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003053473A3 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 04/29/2004 | WO2003042399A9 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 04/29/2004 | WO2003010196A3 Variants and exons of the glyt1 transporter |
| 04/29/2004 | WO2002088380A9 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002055089A9 Immunoassay technique using multispecific molecules |
| 04/29/2004 | WO2001003515A8 Method of obtaining protein isolates and concentrates from colostrum |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040082764 Complex of antibodic and antibiotic with carrier |
| 04/29/2004 | US20040082763 Diagnosis, therapy of Alzheimer's disease; synthetic antibody |
| 04/29/2004 | US20040082762 Humanized antibodies that recognize beta amyloid peptide |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/29/2004 | US20040082047 Protein purification |
| 04/29/2004 | US20040082039 Immunoglobulin fusion proteins |
| 04/29/2004 | US20040082033 Genetic engineering; neutralizing antibodies; vaccines |
| 04/29/2004 | US20040082019 In vitro assay for quantitating secreted antibodies in lymphocyte supernatant for evaluation of vaccine or antigen induced specific antibody secretion from ex vivo circulating antibody-secreting lymphocytes |
| 04/29/2004 | US20040082016 Antibodies specific for papillary fibroblasts as markers for skin quality |
| 04/29/2004 | US20040082010 Neurotrnasmission disorders |
| 04/29/2004 | US20040082004 Protein electrophoresis; separation, purification; amplification, polymerase chain reaction |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081986 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081660 Polypeptide and protein derivatives and process for their preparation |
| 04/29/2004 | US20040081657 Prevention and treatment of amyloidogenic disease |
| 04/29/2004 | US20040081656 Vaccine based on fact that a significant proportion of canine and feline tumours express an oncofetal leucine-rich glycoprotein, known as "5T4" |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081650 Inflammatory mediator antagonists |
| 04/29/2004 | US20040081649 Treating Atopic dermatitis with IgE antagonists |
| 04/29/2004 | US20040081638 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 04/29/2004 | US20040081619 Determination efficiency of antiinflammatory agents; measure damage to heart; measurement, calibration creatine kinase |
| 04/29/2004 | CA2542507A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | CA2504656A1 Therapeutic adjuvant |
| 04/29/2004 | CA2503347A1 Monoclonal antibodies specific for cariogenic bacteria |
| 04/29/2004 | CA2502552A1 Human monoclonal antibodies against cd20 |
| 04/29/2004 | CA2502367A1 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 04/29/2004 | CA2502312A1 Transplantable cell with immune modulator |
| 04/29/2004 | CA2502246A1 Sets of digital antibodies directed against short epitopes, and methods using same |
| 04/29/2004 | CA2501653A1 Human anti-ifn-.gamma. neutralizing antibodies as selective ifn-.gamma. pathway inhibitors |
| 04/29/2004 | CA2496840A1 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/29/2004 | CA2496741A1 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/28/2004 | EP1413586A1 Regulation of the Cre recombinase using a dissociation/re-association system of said recombinase |
| 04/28/2004 | EP1413316A1 Bifunctional conjugates or fusion proteins |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412754A1 Diagnostic methods and agents |
| 04/28/2004 | EP1412752A1 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412747A1 Method and means for detecting alcohol consumption |
| 04/28/2004 | EP1412501A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 04/28/2004 | EP1412499A2 Cytokine polypeptides |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412471A1 Apparatus and method for determining the onset and presence of sepsis conditions |
| 04/28/2004 | EP1412390A2 Agents that activate or inhibit toll-like receptor 9 |
| 04/28/2004 | EP1412389A1 Binding agents with differential activity |
| 04/28/2004 | EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411982A1 Modulators of p-selectin glycoprotein ligand 1 |
| 04/28/2004 | EP1411981A2 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411975A1 Methylation of histone h4 at arginine 3 |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
| 04/28/2004 | EP1411907A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma |
| 04/28/2004 | EP1382688A9 Screening method |
| 04/28/2004 | EP1237929A4 Dendritic cell-specific antibodies |
| 04/28/2004 | EP1073716B1 Improvements in or relating to separation processes |
| 04/28/2004 | EP1058555B1 Costimulatory blockade and mixed chimerism in allotransplantation |
| 04/28/2004 | EP1017703B1 Pentopyranosyl nucleoside, and production and use of the same |
| 04/28/2004 | EP0944723B1 Mammalian chemokines |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0896545B1 Method for producing drug containing hcv hyperimmune globulins |
| 04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0626861B2 Treatment for asthma |
| 04/28/2004 | CN1493052A Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492924A Genes encoding proteolytic enzymes from aspargilli |
| 04/28/2004 | CN1492879A Protein tau |
| 04/28/2004 | CN1492768A Artificial proteins with reduced immunogenicity |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492040A Natural antibody of monoclonal human |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |